Article

Cataract laser system wins technology award

A laser system for cataract surgery that combines a femtosecond laser, three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern scanning technology (Catalys Precision Laser System, OptiMedica) has been selected as a winner of R&D Magazine’s R&D 100 award.

Sunnyvale, CA-A laser system for cataract surgery that combines a femtosecond laser, three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern scanning technology (Catalys Precision Laser System, OptiMedica) has been selected as a winner of R&D Magazine’s R&D 100 award.

Selected by an independent judging panel and the editors of R&D Magazine, the R&D 100 awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.

“This award is a wonderful confirmation of what we are seeing from cataract surgeons around the world who are choosing [our laser system] because they believe it the best technology platform for laser cataract surgery,” said David D. Scott, OptiMedica’s vice president of research and development. “Our goal was to create a system that delivers unsurpassed precision and leaves nothing to chance. It is an honor to have the distinguished panel of R&D 100 judges reward our efforts with this distinction.”

Catalys is FDA 510(k) market cleared and CE mark approved for performing capsulotomy and/or lens fragmentation, and is also CE mark approved for performing corneal incisions during cataract procedures.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.